Efficacy and safety of anti-thrombotic therapy after surgical mitral valve repair: a scoping review
Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ongoing controversy regarding optimal anti-thrombotic therapy post-MVr. This scoping review aimed to summarise current evidence on the safety and efficacy of anti-thrombotic therap...
Saved in:
Main Authors: | Jian Ye, Jenny Chen, Hazal Ece Babadagli, Ricky Turgeon, Erica HZ Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Open Heart |
Online Access: | https://openheart.bmj.com/content/12/1/e003158.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitral Valve Repair
by: Irbaz Hameed, MD, et al.
Published: (2025-03-01) -
Pulmonary Hemorrhage following Edge-to-Edge Mitral Valve Repair
by: Mirna B. Ayache, et al.
Published: (2017-01-01) -
Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends
by: Kris Kumar, et al.
Published: (2023-01-01) -
Percutaneous Mitral Valve Repair versus Optimal Medical Therapy in Patients with Functional Mitral Regurgitation: A Systematic Review and Meta-Analysis
by: Muhammad Uzair Lodhi, et al.
Published: (2019-01-01) -
Transapical Approach for Mitral Valve Repair during Insertion of a Left Ventricular Assist Device
by: Mark J. Russo, et al.
Published: (2013-01-01)